SMOKING CESSATION PROGRAM TESTING WITH CVD SUBJECTS
CVD 受试者戒烟计划测试
基本信息
- 批准号:3348722
- 负责人:
- 金额:$ 12.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-30 至 1986-09-29
- 项目状态:已结题
- 来源:
- 关键词:anxiety cardiovascular disorder clinical chemistry disease /disorder proneness /risk education evaluation /planning gender difference health behavior human morbidity human mortality human subject personality tests saliva self concept social support network thiocyanates tobacco abuse education type A /type B personality
项目摘要
The purpose of this research is to investigate the relative effectiveness
of three different methods of teaching a multi-component smoking cessation
program on the quit smoking behavior of a newly diagnosed cardiovascular
disease (CVD) population. The literature suggests that multi-component
programs which introduce the smokers to a wide range of smoking cessation
strategies are more effective than unidimensional treatments. Yet, little
is known about the relative effectiveness of different methods of teaching
which different markedly in cost.
Subjects (N=320) will be identified by severity of CVD risk, gender, and
habit strength (pack years) and randomly assigned to one of four
interventions (written instructions; individual instructions, group
instructions, and no instruction control). Their quit smoking behavior
will be monitored over a three-year period and self-reports will be
verified with saliva thocyanate levels. In addition to the demographic
data, several other measures will be obtained from each subject including
health and smoking histories, level of social support, several personality
measures, the subject's perceived degree of health risk, their perceptions
of the components of the intervention strategy that were most helpful, and
morbidity and mortality rates.
A potential moderating variable of considerable interest is the client's
degree of health risk. The premise is that exposing persons to the
fear-arousing communication that they have a CVD will lead to increased
attitudinal acceptance of a health recommendation (i.e., to quit smoking)
if the individuals are given the means to achieve the recommendations
(i.e., smoking cessation program). Six additional questions and hypotheses
will be examined.
Logistic and multiple linear regression procedures will be employed in
order to assess the main effects and interactions of the primary predictors
(method-of-instruction and
subject's-perception-of-the-most-helpful-set-of-strategies) on quit rates
and to examine the relationship between success at quiting smoking and
morbidity and mortality.
本研究的目的是调查相对有效性
三种不同的多成分戒烟教学方法
针对新诊断心血管疾病患者的戒烟行为计划
疾病(CVD)人群。 文献表明,多组分
向吸烟者介绍各种戒烟方法的计划
策略比单维治疗更有效。 然而,很少
了解不同教学方法的相对有效性
其成本明显不同。
受试者 (N=320) 将根据 CVD 风险的严重程度、性别和
习惯强度(包年)并随机分配到四个之一
干预措施(书面指示、个人指示、小组指示
指令,无指令控制)。 他们的戒烟行为
将在三年内进行监测,并进行自我报告
通过唾液硫氰酸盐水平进行验证。 除了人口结构外
数据,将从每个受试者那里获得一些其他措施,包括
健康和吸烟史、社会支持水平、多种性格
措施、主体对健康风险的感知程度、他们的看法
干预策略中最有帮助的组成部分,以及
发病率和死亡率。
一个颇受关注的潜在调节变量是客户的
健康风险程度。 前提是使人暴露于
令人恐惧的沟通表明他们患有心血管疾病将导致增加
态度上接受健康建议(即戒烟)
如果个人有办法实现建议
(即戒烟计划)。 六个附加问题和假设
将接受检查。
将采用逻辑回归和多元线性回归程序
为了评估主要预测因素的主要影响和相互作用
(教学方法和
受试者对最有帮助的策略的看法)对戒烟率的影响
并研究戒烟成功与否之间的关系
发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Virginia Hill Rice其他文献
Virginia Hill Rice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Virginia Hill Rice', 18)}}的其他基金
ARAB AMERICAN YOUTH: TOBACCO USE AND INTERVENTION
阿拉伯裔美国青年:烟草使用和干预
- 批准号:
6636984 - 财政年份:2000
- 资助金额:
$ 12.71万 - 项目类别:
ARAB AMERICAN YOUTH: TOBACCO USE AND INTERVENTION
阿拉伯裔美国青年:烟草使用和干预
- 批准号:
6521169 - 财政年份:2000
- 资助金额:
$ 12.71万 - 项目类别:
ARAB AMERICAN YOUTH: TOBACCO USE AND INTERVENTION
阿拉伯裔美国青年:烟草使用和干预
- 批准号:
6126703 - 财政年份:2000
- 资助金额:
$ 12.71万 - 项目类别:
ARAB AMERICAN YOUTH: TOBACCO USE AND INTERVENTION
阿拉伯裔美国青年:烟草使用和干预
- 批准号:
6388076 - 财政年份:2000
- 资助金额:
$ 12.71万 - 项目类别:
ARAB AMERICAN YOUTH: TOBACCO USE AND INTERVENTION
阿拉伯裔美国青年:烟草使用和干预
- 批准号:
6743627 - 财政年份:2000
- 资助金额:
$ 12.71万 - 项目类别:
EVALUATION OF THE EFFECTS OF PRE-PROCEDURAL TEACHING
预程序教学的效果评估
- 批准号:
3391205 - 财政年份:1986
- 资助金额:
$ 12.71万 - 项目类别:
SMOKING CESSATION PROGRAM TESTING WITH CVD SUBJECTS
CVD 受试者戒烟计划测试
- 批准号:
3348723 - 财政年份:1985
- 资助金额:
$ 12.71万 - 项目类别:
SMOKING CESSATION PROGRAM TESTING WITH CVD SUBJECTS
CVD 受试者戒烟计划测试
- 批准号:
3348724 - 财政年份:1985
- 资助金额:
$ 12.71万 - 项目类别:
相似国自然基金
整合衰老动态表观组学和分子表型数量性状遗传位点解析心血管疾病致病变异
- 批准号:32300547
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
心血管疾病与认知衰弱双向演化关系与整合照护策略研究
- 批准号:72304207
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
克隆性造血的发生机理及其诱发心血管疾病的机制探究
- 批准号:82300136
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态DNA分子器件的心血管疾病相关miRNA单核苷酸多态性的检测研究
- 批准号:82370516
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
数据驱动的心血管疾病区域协同医疗服务研究
- 批准号:72301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
使用不与生理配体竞争的配体导向纳米颗粒口服胰岛素
- 批准号:
10399664 - 财政年份:2020
- 资助金额:
$ 12.71万 - 项目类别:
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
使用不与生理配体竞争的配体导向纳米颗粒口服胰岛素
- 批准号:
10373829 - 财政年份:2020
- 资助金额:
$ 12.71万 - 项目类别:
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
使用不与生理配体竞争的配体导向纳米颗粒口服胰岛素
- 批准号:
10580808 - 财政年份:2020
- 资助金额:
$ 12.71万 - 项目类别:
Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands
使用不与生理配体竞争的配体导向纳米颗粒口服胰岛素
- 批准号:
10027854 - 财政年份:2020
- 资助金额:
$ 12.71万 - 项目类别:
Development of dihydrocaffeic acid and malvidin- 3 - glucoside for the treatment of depression and anxiety disorders
开发二氢咖啡酸和锦葵素-3-葡萄糖苷用于治疗抑郁症和焦虑症
- 批准号:
10045507 - 财政年份:2019
- 资助金额:
$ 12.71万 - 项目类别: